Gene Solutions Showcases Global Evidence and Responsible Innovation

Gene Solutions, a biotechnology company focused on “accessible and responsible genomics,” took part as a Premier Partner in the 30th International Conference on Prenatal Diagnosis and Therapy (ISPD 2026), held virtually from July 7–9. The company presented Asia-led real-world evidence from large-scale NIPT-integrated carrier screening and discussed AI-enabled pregnancy-risk assessment and minimally invasive molecular approaches in women’s health. Gene Solutions’ program included an industry symposium and scientific presentations addressing how genomics and epigenomics could expand prenatal and genetic counselling. A reported study screened 225,092 Asian pregnant women in multiple countries from February 2025 to February 2026 for 18 recessive conditions, finding more than one in four carried at least one.